Medical Devices Startups

Curi Bio provides a preclinical drug development platform combining 3D human tissue models of disease (cardiac and skeletal muscle), biosystems for functional analysis, and AI/ML-based insights to assess drug safety, efficacy, and potency. It serves pharmaceutical and biotech R&D teams working on drug discovery.

1 investor

Curiato develops a smart surface monitoring system that uses the bed surface to continuously track patient pressure and humidity, generating clinical-grade data and insights. Its interoperable platform is designed for healthcare facilities to integrate with their data ecosystems and command centre applications.

1 investor

Curida is a contract manufacturing organization specializing in pharmaceutical liquid formulations and biologics, operating under strict EU GMP and ISO certifications to ensure product quality and compliance. The company serves pharmaceutical companies and life science organizations requiring manufacturing and technology transfer services.

1 investor

Curileum develops regenerative medicine therapies targeting intestinal stem cells to prevent colorectal cancer. The company works with specialist partners in chemistry and regulatory affairs to advance its clinical pipeline.

1 investor

Curiosis is a biotech company focusing on bio-pharmaceutical supply chain components and materials. The company operates in the medical device and biotechnology sector in South Korea.

1 investor

Current Clinic operates a network of healthcare centers specializing in the diagnosis and treatment of atrial fibrillation and other cardiac arrhythmias. The company delivers cardiology services outside traditional hospital settings to reduce costs and improve access to care.

1 investor

Curtana Pharmaceuticals develops small molecule drugs targeting cancer stem cells in brain tumors, specifically gliomas and related CNS malignancies. The company focuses on OLIG2 inhibition to overcome treatment resistance and recurrence in pediatric and adult brain cancers.

1 investor

Curve Dental provides practice management and clinical software for dental practices, offering integrated charting, scheduling, insurance verification, patient billing, and ambient AI-powered documentation tools.

1 investor

CurveBeam AI develops weight-bearing CT imaging systems (such as HiRise and InReach) that produce high-resolution 3D renderings, multiplanar CT volumes, and reconstructed X-ray images for orthopedic diagnostics. Its compact, point-of-care devices are used by orthopedic clinics, emergency centers, and medical professionals, with a German subsidiary serving the local market.

1 investor

CurveBeam AI develops point-of-care cone beam CT imaging systems combined with AI and deep learning tools for orthopedic and bone health applications, including fragility fracture prevention. The company serves orthopedic and podiatric healthcare providers seeking diagnostic imaging and complementary software solutions.

1 investor

Cuspa develops a minimally invasive medical device using an artificial cusp that merges with the native aortic valve to treat aortic regurgitation, addressing a gap for patients with moderate to severe AR who lack repair options. The company operates in the medical device sector focused on structural heart and aortic valve disease treatment.

1 investor

CustomSurg develops digital solutions for orthopaedic trauma surgery, combining clinical expertise with data science and advanced technology. The company serves surgeons and clinical institutions globally.

1 investor

Customy is an ISO 13485 certified medical software (SaMD) company that develops tools for processing CT/MRI medical images into 3D models, supporting 3D printing and preoperative virtual surgery planning. Its platform serves surgeons, radiologists, and biomedical engineers, and the company also designs patient-specific implants, surgical guides, and anatomical models for craniofacial reconstructions.

1 investor

CVAid develops an AI-powered stroke triage platform using standard smartphones and mobile applications to enable early diagnosis, in-hospital process management, and post-discharge follow-up. The company serves healthcare providers and stroke patients globally.

1 investor

Cyber Insight develops product-security decision infrastructure that combines cybersecurity expertise and AI engineering to help regulated manufacturers convert vulnerability findings into traceable, product-specific security decisions. Its DARA reasoning platform powers the Zylentix application for MedTech and ThreatFinder for OEM/API partners.

1 investor

Cyberdontics develops a handheld intraoral scanner using OCT (optical coherence tomography) imaging combined with AI to detect caries and plan dental treatment, along with a dental robotics system aimed at performing restorative procedures such as crowns and fillings faster and more accurately. The products target dentists in restorative and diagnostic dentistry and are not yet FDA-cleared or available for sale in the U.S.

1 investor

Cyclops Medtech develops a portfolio of vestibular diagnostic and therapy products—including videonystagmography (VNG/VOG), video head impulse testing (vHIT), dynamic visual acuity, stabilometry platforms, VR-based vestibular rehabilitation, and a smart balance board—to diagnose and treat dizziness and balance disorders. Its tools serve clinicians across neurotology, neurology, physiotherapy, audiology, and ophthalmology.

1 investor

Cyclotek manufactures and distributes PET radiopharmaceuticals and radioactive medical devices for hospitals, research institutions, and clinical partners across Australia and New Zealand. The company provides GMP manufacturing, supply chain coordination, and translational support to enable molecular imaging diagnostics and therapy.

1 investor

CyGenica develops a targeted intracellular drug delivery technology, the GEENIE platform, to deliver therapeutic molecules into cells more safely and efficiently. Its work focuses on treatments for oncology and rare genetic diseases, serving biopharmaceutical companies developing therapies.

1 investor

Cygnus Med develops the EndoSphinx, an endovascular access system that provides continuous arterial blood pressure monitoring while eliminating blood loss and preventing clotting inside the guiding catheter during endovascular procedures. The device is aimed at clinicians performing endovascular interventions.

1 investor

CynosBio develops and commercializes regenerative medicine products, including cell-based treatments for cartilage damage, joint disorders, and liver disease. The company is based in Japan and pursues global expansion, particularly in the United States.

1 investor

Cyrano Therapeutics is a clinical-stage regenerative medicine company developing CYR-064, a nasal therapy for post-viral smell loss (hyposmia) and associated loss of taste. It serves patients with anosmia and is advancing its lead candidate through clinical trials toward Phase 3.

1 investor

Cyrebro Neurosignals develops a neurotechnology platform using EEG and AI to analyze brain activity in real time, providing digital neuromarkers for healthcare applications and consumer product development. The platform serves healthcare professionals, clinical researchers, and consumer product companies in mental health, neurological treatment, and product optimization.

1 investor

cystetic Medicines is a drug development company creating an inhaled dry-powder therapy based on an FDA-approved antifungal compound to treat cystic fibrosis, targeting the roughly 10% of patients not helped by existing modulators. The company focuses on accessible, scalable treatment using aerodynamically engineered nanoparticle delivery.

1 investor